FilingReader Intelligence
Alembic Pharma gets INR 800 crore enhanced credit facilities
July 26, 2025 at 08:39 AM UTC•By FilingReader AI
Alembic Pharmaceuticals Limited had its credit rating reaffirmed at CRISIL AA+/Stable by CRISIL Ratings Limited on July 25, 2025.
The company's total bank loan facilities were enhanced to INR 800 crore from INR 600 crore. The additional facilities are spread across multiple banks including HDFC Bank, Kotak Mahindra Bank, HSBC, Axis Bank, Citibank, and State Bank of India.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:APLLTD•Bombay Stock Exchange
News Alerts
Get instant email alerts when ALEMBIC PHARMACEUTICALS publishes news
Free account required • Unsubscribe anytime